Reporting Trends of Outcome Measures in Phase II and Phase III Trials Conducted in Advanced-Stage Non-small-cell Lung Cancer
出版年份 2013 全文链接
标题
Reporting Trends of Outcome Measures in Phase II and Phase III Trials Conducted in Advanced-Stage Non-small-cell Lung Cancer
作者
关键词
Clinical trials, Non-small-cell lung cancer, Advanced stage, Phase II trials, Phase III trials, Primary outcomes, Secondary outcomes
出版物
LUNG
Volume 191, Issue 4, Pages 313-319
出版商
Springer Nature
发表日期
2013-05-29
DOI
10.1007/s00408-013-9479-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials
- (2013) Silvy Laporte et al. BMJ Open
- Personalized Tumor Response Assessment in the Era of Molecular Medicine: Cancer-Specific and Therapy-Specific Response Criteria to Complement Pitfalls of RECIST
- (2012) Mizuki Nishino et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Assessment of quality of life in advanced non-small-cell lung cancer: An overview of recent randomized trials
- (2012) Everardo D. Saad et al. CANCER TREATMENT REVIEWS
- Factors Affecting Efficacy and Safety of Add-On Combination Chemotherapy for Non-Small-Cell Lung Cancer: A Literature-Based Pooled Analysis of Randomized Controlled Trials
- (2012) Kouichi Inoue et al. LUNG
- Issues surrounding clinical trial endpoints in solid malignancies with a focus on metastatic non-small cell lung cancer
- (2012) Edward B. Garon LUNG CANCER
- Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer
- (2012) Katsuyuki Hotta et al. LUNG CANCER
- Targeted therapies for advanced non-small-cell lung cancer: Current status and future implications
- (2011) Ana Custodio et al. CANCER TREATMENT REVIEWS
- Effectiveness of adaptive designs for phase II cancer trials
- (2011) Martha Fors López et al. Contemporary Clinical Trials
- Health-Related Quality of Life in Non–Small-Cell Lung Cancer: An Update of a Systematic Review on Methodologic Issues in Randomized Controlled Trials
- (2011) Lily Claassens et al. JOURNAL OF CLINICAL ONCOLOGY
- Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?
- (2010) J. C. Soria et al. ANNALS OF ONCOLOGY
- Progression-Free Survival
- (2010) David Lebwohl et al. CANCER JOURNAL
- Overall Survival: A Gold Standard in Search of a Surrogate
- (2010) Sen H. Zhuang et al. CANCER JOURNAL
- Analysis of progression-free survival data using a discrete time survival model that incorporates measurements with and without diagnostic error
- (2010) Sally Hunsberger et al. Clinical Trials
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Alternate Endpoints for Screening Phase II Studies
- (2009) N. Dhani et al. CLINICAL CANCER RESEARCH
- Issues in Using Progression-Free Survival When Evaluating Oncology Products
- (2009) Thomas R. Fleming et al. JOURNAL OF CLINICAL ONCOLOGY
- Methodological aspects of lung cancer clinical trials in the era of targeted agents
- (2009) Massimo Di Maio et al. LUNG CANCER
- Is Response Rate Relevant to the Phase II Trial Design of Targeted Agents?
- (2008) Afshin Dowlati et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started